Target intelligence / Profile preview

Thyroid cancer-associated transcript 155 (THCAT155)

Target: THCAT155
Molecular classification: Other (non-coding RNA, ncRNA), ncRNA

Overview

Thyroid cancer-associated transcript 155 (THCAT155) is a non-coding RNA (ncRNA) identified and classified as such in public genomic resources. It is located on chromosome 12 (chr12:3,483,714-3,492,819, hg38 coordinates), with several transcript isoforms recorded. There is no evidence that THCAT155 is a receptor, enzyme, transporter, or other classical therapeutic target. Its biological function and role in thyroid cancer remain unclear, and it is not currently associated with known drug interactions, mechanisms of action, or established use as a clinical biomarker. Current evidence is limited to genomic annotation and gene cataloging[1][2].

Other names: THCAT155

Disease associations

CancerThyroid cancer

Beyond the preview

Go deeper on Thyroid cancer-associated transcript 155 (THCAT155).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid cancer-associated transcript 155 (THCAT155).

Explore the full profile